Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1777-1778
doi: 10.1161/CIRCULATIONAHA.108.191124
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;118:1777-1778.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
 
Strong evidence is available to support the use of statins to reduce the risk of recurrent cardiovascular events in patients with native coronary artery disease; however, less is known about the benefits of statins after coronary artery bypass grafting (CABG). Previous randomized controlled trials investigating cholesterol reduction after CABG enrolled relatively healthy male patients <65 years of age who had undergone surgery several years earlier; however, CABG patients in the current era are older, have more coexisting conditions, and are increasingly likely to be women. We sought to clarify the role of statin therapy in this context and conducted a retrospective cohort study of 7503 CABG patients ≥65 years old who had and had not received statins within 1 month of hospital discharge after CABG. Our primary outcomes were all-cause mortality and freedom from major adverse cardiovascular events. Multivariable and propensity score–adjusted analysis demonstrated that statin use within 1 month of CABG discharge independently reduced the risk of all-cause mortality (adjusted hazard ratio 0.82, 95% confidence interval 0.72 to 0.94) and major adverse cardiovascular events (adjusted hazard ratio 0.89, 95% confidence interval 0.81 to 0.98) compared with nonuse. Thus, early statin therapy independently improved postoperative outcomes, and these results confirm those of earlier studies within a contemporary surgical population. Our findings endorse the view that essentially all patients should be prescribed long-term statin therapy after CABG. See p 1785.


*    Morphological and Physiological Predictors of Fetal Aortic Coarctation
 
Undiagnosed coarctation can cause neonatal circulatory collapse and death, but morbidity is reduced by antenatal detection and appropriate perinatal management. . . . [Full Text of this Article]


Related Articles:

Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
Pieter J. Vlaar, Tone Svilaas, Kevin Damman, Bart J.G.L. de Smet, Jan G.P. Tijssen, Hans L. Hillege, and Felix Zijlstra
Circulation 2008 118: 1828-1836. [Abstract] [Full Text]

Presence of Older Thrombus Is an Independent Predictor of Long-Term Mortality in Patients With ST-Elevation Myocardial Infarction Treated With Thrombus Aspiration During Primary Percutaneous Coronary Intervention
Miranda C.A. Kramer, Allard C. van der Wal, Karel T. Koch, Johanna P.H.M. Ploegmakers, René J. van der Schaaf, José P.S. Henriques, Jan Baan, Jr, Saskia Z.H. Rittersma, Marije M. Vis, Jan J. Piek, Jan G.P. Tijssen, and Robbert J. de Winter
Circulation 2008 118: 1810-1816. [Abstract] [Full Text]

Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts
Laura Mauri, Treacy S. Silbaugh, Robert E. Wolf, Katya Zelevinsky, Ann Lovett, Zheng Zhou, Frederic S. Resnic, and Sharon-Lise T. Normand
Circulation 2008 118: 1817-1827. [Abstract] [Full Text]

Cardiovascular Stress Hyperreactivity in Babies of Smokers and in Babies Born Preterm
Gary Cohen, Silvano Vella, Heather Jeffery, Hugo Lagercrantz, and Miriam Katz-Salamon
Circulation 2008 118: 1848-1853. [Abstract] [Full Text]

Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis
Farouc A. Jaffer, Claudio Vinegoni, Michael C. John, Elena Aikawa, Herman K. Gold, Aloke V. Finn, Vasilis Ntziachristos, Peter Libby, and Ralph Weissleder
Circulation 2008 118: 1802-1809. [Abstract] [Full Text]

Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages: Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions
Laurent Yvan-Charvet, Carrie Welch, Tamara A. Pagler, Mollie Ranalletta, Mohamed Lamkanfi, Seongah Han, Minako Ishibashi, Rong Li, Nan Wang, and Alan R. Tall
Circulation 2008 118: 1837-1847. [Abstract] [Full Text]

Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Alexander Kulik, M. Alan Brookhart, Raisa Levin, Marc Ruel, Daniel H. Solomon, and Niteesh K. Choudhry
Circulation 2008 118: 1785-1792. [Abstract] [Full Text]